FIELD: medicine; dermatology.
SUBSTANCE: in addition to Griseofulvin, Pioployphage is introduced orally in dosage 30-50 ml or on 1-2 tablets twice a day within 14 days.
EFFECT: antibacterial action, nonspecific phagocytosis stimulation, intensified immune response on infestant antigen, escaping complications associated with secondary pyogenic infection.
4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF ZOOANTHROPONOSIS TRICHOPHYTOSIS IN CHILDREN | 2005 |
|
RU2289401C1 |
| METHOD FOR EXAMINING PATIENTS SUFFERING ZOOANTROPONOZE TRICHOPHYTOSIS TO DETERMINE RISK OF EITHER TRANSLATION OF INFILTRATIVE TO SUPPURANT FORM, OR CHRONIC CLINICAL COURSE OF LATTER | 2012 |
|
RU2510025C1 |
| METHOD FOR PREDICTING PROBABILITY IN ZOOANTHROPONOSIC TRICHOPHYTOSIS TRANSITION FROM INFILTRATIVE TO PURULENT FORM | 2005 |
|
RU2284038C1 |
| METHOD OF PREDICTING TRANSFER OF INFILTRATIVE FORM OF TRICHOPHYTOSIS INTO SUPPURATIVE | 2011 |
|
RU2460464C1 |
| AGENT FOR EXTERNAL TREATMENT OF INFILTRATIVE SUPPURATIVE TRICHOPHYTOSIS CAPITIS | 2008 |
|
RU2372090C1 |
| AGENT FOR EXTERNAL TREATMENT OF INFILTRATIVE-SUPPURATIVE FORM OF ZOOANTROPONOZE TRICHOPHYTOSIS OF SCALP | 2019 |
|
RU2722187C1 |
| METHOD FOR PREDICTING THE TRANSITION OF AN INFILTRATIVE FORM INTO A SUPPURATION OF A DISEASE IN A PATIENT WITH ZOOANTROPONOZE TRICHOPHYTOSIS | 2019 |
|
RU2714318C1 |
| AGENT FOR TOPICAL TREATMENT OF INFILTRATIVE-SUPPURANT TRICHOPHYTOSIS CAPITIS | 2011 |
|
RU2467753C1 |
| METHOD FOR TREATMENT OF INFILTRATIVE SUPPURATIVE FORMS OF SCALP TRICHOPHYTOSIS | 2007 |
|
RU2347564C1 |
| AGENT FOR TOPICAL TREATMENT OF INFILTRATIVE-SUPPURATIVE FORMS OF HEAD HAIR TRICHOPHYTOSIS | 2005 |
|
RU2276609C1 |
